STOUGHTON W. VICKERY

CIK 00010706001 companySEATTLE, WA

SEC Profile

Transactions

Companies

Filings

CIK

0001070600

Recent Transactions

23 trades

Exercise/Conversion
Cascadian Therapeutics, Inc.
Restricted Share Unit (RSU)
2014-03-11−19,352→ 0 total
Tax Payment
Cascadian Therapeutics, Inc.
Common Stock
2014-03-11$3.65/sh−4,838→ 48,736 total
Exercise/Conversion
Cascadian Therapeutics, Inc.
Common Stock
2014-03-11+19,352→ 53,574 total
Award
Cascadian Therapeutics, Inc.
Restricted Share Unit (RSU)
2013-06-13+16,042→ 16,042 total
Tax Payment
Cascadian Therapeutics, Inc.
Common Stock
2013-06-09$1.86/sh−1,135→ 34,222 total
Award
Cascadian Therapeutics, Inc.
Common Stock
2012-06-07$3.67/sh+8,174→ 35,357 total
Tax Payment
Cascadian Therapeutics, Inc.
Common Stock
2012-06-03$3.51/sh−2,021→ 27,183 total
Exercise/Conversion
Cascadian Therapeutics, Inc.
Common Stock
2012-05-03+989→ 29,451 total
Tax Payment
Cascadian Therapeutics, Inc.
Common Stock
2012-05-03$4.15/sh−247→ 29,204 total
Exercise/Conversion
Cascadian Therapeutics, Inc.
Restricted Share Units
2012-05-03−989→ 0 total
Exercise/Conversion
Cascadian Therapeutics, Inc.
Common Stock
2011-12-31+2,388→ 29,059 total
Tax Payment
Cascadian Therapeutics, Inc.
Common Stock
2011-12-31$7.58/sh−597→ 28,462 total
Exercise/Conversion
Cascadian Therapeutics, Inc.
Restricted Share Units
2011-12-31−2,388→ 0 total
Tax Payment
Cascadian Therapeutics, Inc.
Common Stock
2011-12-04$6.86/sh−1,546→ 26,671 total
Exercise/Conversion
Cascadian Therapeutics, Inc.
Restricted Share Units
2011-06-12−2,076→ 0 total
Exercise/Conversion
Cascadian Therapeutics, Inc.
Common Stock
2011-06-12+2,076→ 28,217 total
Award
Cascadian Therapeutics, Inc.
Common Stock
2011-06-09+4,538→ 26,141 total
Exercise/Conversion
Cascadian Therapeutics, Inc.
Restricted Share Units
2010-12-14−3,166→ 0 total
Exercise/Conversion
Cascadian Therapeutics, Inc.
Common Stock
2010-12-14+3,166→ 21,603 total
Award
Cascadian Therapeutics, Inc.
Common Stock
2010-06-03+8,086→ 18,437 total
Award
Cascadian Therapeutics, Inc.
Common Stock
2009-12-04+6,185→ 10,351 total
Award
Cascadian Therapeutics, Inc.
Restricted Share Units
2009-03-11+19,352→ 19,352 total
Award
Cascadian Therapeutics, Inc.
Restricted Stock Units
2009-03-11+21,428→ 21,428 total

Companies

Cascadian Therapeutics, Inc.
Director

Recent Filings

Address

2601 FOURTH AVENUE SUITE 500

SEATTLE, WA, 98121

View on SEC.gov